Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: trastuzumab, docetaxel and carboplatin in dose dense regimen
Sponsor: University of Miami
Collaborators: Aventis Pharmaceuticals